Summary & Overview
HCPCS E2510: Speech-Generating Device, Synthesized Speech
HCPCS Level II code E2510 designates a speech-generating device with synthesized speech that allows multiple methods for composing messages and multiple access modalities. This code captures durable medical equipment and technology that supports communication for individuals with complex speech impairments; it is an important classification nationally because it ties clinical need to coverage pathways for augmentative and alternative communication (AAC) interventions. Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of what E2510 represents, typical sites of service, and the clinical context for device use. The publication summarizes payer coverage patterns and common modifiers associated with HCPCS claims, presents national reimbursement benchmarks where available, and highlights relevant policy and billing considerations affecting access to AAC devices. Clinical context covers the role of synthesized-speech devices in restoring functional communication, typical interdisciplinary involvement (e.g., speech-language pathologists, rehabilitation teams), and scenarios that commonly trigger device provision. Data not available in the input is noted where applicable, and the report focuses on nationally relevant guidance rather than state-specific policy.
Billing Code Overview
HCPCS Level II code E2510 describes a speech generating device with synthesized speech that permits multiple methods of message formulation and multiple methods of device access. The service type is augmentative and alternative communication (AAC) device provision, encompassing evaluation, device configuration, and device delivery aimed at supporting individuals with significant speech impairments.
Typical site of service includes outpatient clinics, rehabilitation centers, specialty communication clinics, school-based therapy settings, and home/facility deployment when devices are issued for patient use outside the clinic.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or child with severe expressive communication impairment due to neurologic conditions such as amyotrophic lateral sclerosis, cerebral palsy, stroke-related aphasia with motor speech deficits, traumatic brain injury, or progressive neurodegenerative disease. The patient has adequate cognition to formulate messages but is unable to produce intelligible natural speech. Evaluation occurs in an outpatient or home-based durable medical equipment (DME) setting following referral from a speech-language pathologist (SLP), physiatrist, neurologist, or primary care clinician. The clinical workflow includes a comprehensive communication needs assessment by an SLP, trial of access methods (touchscreen, switch scanning, eye gaze, head/eye tracking), selection of a speech generating device meeting the functional requirements described by E2510, customization of vocabulary and phrase sets, training for the patient and caregivers, and documentation of functional impact and device training sessions for billing and DME provision. Typical sites of service include outpatient rehabilitation clinics, hospital-based outpatient SLP services, specialized assistive technology centers, and patient homes for delivery and training visits.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when additional work, time, and effort are required for device customization or extensive SLP evaluation beyond typical time. |